Moderna Secures Third EU-Authorized Vaccine With mNEXSPIKE, Supporting Protection Against Endemic COVID-19 As European Market Reopens In 2026

Moderna -1.29%

Moderna

MRNA

53.56

-1.29%

mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe